Close Menu

marketing agreement

Magellan anticipates marketing a family of Miacom sepsis tests in the US for research use only, while starting clinical trials in preparation of submission to the US Food and Drug Administration.

Under one deal, AstraNet will sell Norton's protein aggregation monitoring device in Europe, while under another, Advanced Scientific Technologies will sell PAM in the mid-Atlantic region.

Health Diagnostic Laboratory will offer the galectin-3 test to physicians along with its own cardiovascular tests.

IDT will produce the assays and market them through an online catalog directly to customers of Quanta.

The deal will make Ambry the preferred provider of genetic carrier screening for LABS and give LABS' customers access to Ambry's genetic screen for identifying carriers of severe and common childhood diseases.

The firms will co-develop a new tissue-based imaging and analysis solutions for protein biomarkers.

Seahorse Extracellular and Flux Analyzers provide a kinetic method of measuring mitochondrial respiration and glycolysis, the two major energy-producing pathways, in living cells in a microplate, the company said.

Shimadzu's LC and GC systems sold in the US will come with Phenomenex columns, under the terms of the deal.

The deal will take Novartis into the blood genotyping market.

LabCorp will be XDx's preferred third-party, non-hospital provider for phlebotomy and specimen processing for all XDx AlloMap molecular expression tests conducted in North America.

Pages

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.